Financial News
Articles published by Galera Therapeutics
Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates
March 28, 2024
From Galera Therapeutics
Via GlobeNewswire
Tickers
GRTX
Galera to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
September 05, 2023
From Galera Therapeutics
Via GlobeNewswire
Tickers
GRTX
Galera Presents Additional Chronic Kidney Disease Data from ROMAN Trial at 2023 ASCO Annual Meeting
June 05, 2023
From Galera Therapeutics
Via GlobeNewswire
Tickers
GRTX
Galera Announces FDA Orphan Drug Designation Granted to Rucosopasem for Pancreatic Cancer
May 18, 2023
From Galera Therapeutics
Via GlobeNewswire
Tickers
GRTX
Galera Expands Commercial Leadership Team
May 01, 2023
From Galera Therapeutics
Via GlobeNewswire
Tickers
GRTX
Galera Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Updates
March 08, 2023
From Galera Therapeutics
Via GlobeNewswire
Tickers
GRTX
Galera Therapeutics Announces Pricing of Registered Direct Offering of $30 Million of Common Stock and Warrants
February 15, 2023
From Galera Therapeutics
Via GlobeNewswire
Tickers
GRTX
Galera Announces FDA Acceptance and Priority Review of Avasopasem NDA for Radiotherapy-Induced Severe Oral Mucositis
February 15, 2023
From Galera Therapeutics
Via GlobeNewswire
Tickers
GRTX
Galera to Present at Piper Sandler Annual Healthcare Conference
November 22, 2022
From Galera Therapeutics
Via GlobeNewswire
Tickers
GRTX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.